Getein Biotech, Inc (SHA:603387)
8.70
+0.08 (0.93%)
Jul 22, 2026, 3:00 PM CST
Getein Biotech Market Cap
Getein Biotech has a market cap or net worth of 4.41 billion as of July 22, 2026. Its market cap has increased by 1.05% in one year.
Market Cap
4.41B
Enterprise Value
3.56B
Revenue
1.08B
Ranking
n/a
PE Ratio
18.88
Stock Price
8.70
ChartMarket Cap Chart
Since July 17, 2017, Getein Biotech's market cap has increased from 4.23B to 4.41B, an increase of 4.33%. That is a compound annual growth rate of 0.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 4.41B | 3.94% |
| Dec 31, 2025 | 4.24B | 1.45% |
| Dec 31, 2024 | 4.18B | -25.00% |
| Dec 29, 2023 | 5.58B | -12.00% |
| Dec 30, 2022 | 6.34B | -12.61% |
| Dec 31, 2021 | 7.25B | -18.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen YHLO Biotech | 5.22B |
| HOB Biotech Group Corp.,Ltd | 5.18B |
| Nanjing Vishee Medical Technology | 4.71B |
| Shenzhen Lifotronic Technology | 4.61B |
| Shanghai Sanyou Medical | 4.50B |
| Contec Medical Systems Co.,Ltd | 4.27B |
| Wuhan Huakang Century Clean Technology | 4.17B |
| Hangzhou AGS MedTech | 4.12B |